Related Experiment Video

Updated: Jun 21, 2026

Detection of Low Copy Number Integrated Viral DNA Formed by In Vitro Hepatitis B Infection
11:14

Detection of Low Copy Number Integrated Viral DNA Formed by In Vitro Hepatitis B Infection

Published on: November 7, 2018

Dual chronic hepatitis B virus and hepatitis C virus infection

Chun-Jen Liu1, Pei-Jer Chen, Ding-Shinn Chen

  • 1Department of Internal Medicine, Graduate Institute of Clinical Medicine, Hepatitis Research Center, National Taiwan University College of Medicine and National Taiwan University Hospital, 1 Chang-Te Street, Taipei, 10002, Taiwan, cjliu@ntu.edu.tw.

Hepatology International
|August 12, 2009
PubMed

Insights

Dual infections with hepatitis B (HBV) and C (HCV) viruses present complex challenges. Further research is needed to understand viral interactions, occult HBV, and optimal treatment strategies for co-infected patients.

Area of Science:

  • Hepatology
  • Virology
  • Immunology

Background:

  • Dual hepatitis B virus (HBV) and hepatitis C virus (HCV) infections are prevalent globally.
  • Significant unresolved clinical and pathogenetic issues exist regarding these co-infections.

Purpose of the Study:

  • To investigate the dynamics of HBV-HCV interactions within hepatocytes.
  • To determine the prevalence and clinical impact of occult HBV in chronic HCV patients.
  • To explore optimal treatment strategies and management of HBV reactivation in co-infected individuals.

Main Methods:

  • Review of clinical and in vitro studies on viral interactions.
  • Analysis of treatment outcomes for dual HBV/HCV infections.
  • Investigation of HBV reactivation and HBsAg loss mechanisms.

Main Results:

  • Combination therapy (peginterferon alfa-2a and ribavirin) shows similar efficacy and safety in dually infected patients compared to HCV monoinfection.
  • One-third of dually infected patients with undetectable HBV DNA pre-treatment experienced HBV reactivation post-treatment.
  • Approximately 10% of dually infected patients lost hepatitis B surface antigen (HBsAg).

Conclusions:

  • Understanding HBV-HCV interactions within hepatocytes is crucial for future immunopathogenetic studies.
  • Further research is required to establish optimal treatment strategies and prevent HBV reactivation in co-infected patients.
  • Mechanisms underlying HBsAg loss in dually infected individuals need elucidation.

More Related Videos

Real-Time Polymerase Chain Reaction-Based Detection and Quantification of Hepatitis B Virus DNA04:11

Real-Time Polymerase Chain Reaction-Based Detection and Quantification of Hepatitis B Virus DNA

Published on: December 15, 2023

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Viruses with RNA Genomes01:29

Viruses with RNA Genomes

RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...